Sentinel lymph node biopsy (SLNB) is not routinely recommended for T1a cutaneous melanoma due to the overall low risk of positivity. Prognostic factors for SLN positivity (SLN+) in this population are poorly characterized.
Continue Reading→Sentinel lymph node biopsy (SLNB) is not routinely recommended for T1a cutaneous melanoma due to the overall low risk of positivity. Prognostic factors for SLN positivity (SLN+) in this population are poorly characterized.
Continue Reading→